Roswell Park Cancer Institute Experts Discuss Lung Cancer Screening

Cancer screening saves lives, but when it comes to lung cancer, early detection has long been a challenge. Thankfully, the outlook for those at highest risk of this deadly disease is improving thanks to new lung cancer screening techniques.

Three leading cancer experts from Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., discussed and answered your questions about lung cancer screening during a live, interactive online video chat recorded on January 21, 2015.

The Lung Cancer Screening Program at Roswell Park is well established and has evolved to include the most innovative technologies proven to help catch lung cancers at their earliest, most curable stages. The multidisciplinary panel discusses the hope that lung cancer screening offers for those at high risk of the disease, such as long-term smokers.

What is the research behind lung cancer screening?

Who is eligible?

What tests are involved?

How much does it cost, and will my insurance cover it?

Panel Members

Samjot Dhillon, MD

Samjot Dhillon is Chief of Pulmonary Medicine, Clinical Chief for Thoracic Medicine Clinics and Co-Chief of Endoscopy at Roswell Park Cancer Institute. Dr. Dhillon specializes in lung cancer screening and the diagnosis and staging of pulmonary malignancies.

Mary Reid, MSPH, PhD

Mary Reid is the Director of Collaborative Research in the Department of Medicine and a key facilitator in the Lung Cancer Screening Program at Roswell Park. Her research focuses on the early detection of lung cancer and the evaluation of genetic biomarkers in high-risk populations.

Pamela Germain, MBA

Pamela Germain is the Vice President of Managed Care and Outreach at Roswell Park. She educates health insurance companies on new, innovative cancer treatments to ensure patients receive coverage for the care they need and negotiates reimbursement for covered services.